MediciNova, Inc. (MNOV)
NASDAQ: MNOV · Real-Time Price · USD
2.000
+0.050 (2.56%)
Nov 21, 2024, 4:00 PM EST - Market closed
MediciNova Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | - | 1 | - | 4.04 | - | - | |
| Gross Profit | - | 1 | - | 4.04 | - | - | |
| Selling, General & Admin | 5.04 | 5.24 | 5.48 | 5.72 | 6.69 | 7.95 | |
| Research & Development | 6.94 | 5.66 | 9.14 | 8.54 | 7.48 | 6.08 | |
| Operating Expenses | 11.98 | 10.9 | 14.63 | 14.25 | 14.18 | 14.03 | |
| Operating Income | -11.98 | -9.9 | -14.63 | -10.22 | -14.18 | -14.03 | |
| Interest & Investment Income | 1.72 | 1.83 | 0.81 | 0.14 | 0.36 | 1.15 | |
| Other Non Operating Income (Expenses) | -0.03 | -0.5 | -0.25 | -0.06 | -0.04 | -0.05 | |
| Pretax Income | -10.29 | -8.57 | -14.07 | -10.13 | -13.86 | -12.93 | |
| Income Tax Expense | 0 | 0 | 0 | 0 | -0 | 0.01 | |
| Net Income | -10.29 | -8.57 | -14.07 | -10.13 | -13.85 | -12.94 | |
| Net Income to Common | -10.29 | -8.57 | -14.07 | -10.13 | -13.85 | -12.94 | |
| Shares Outstanding (Basic) | 49 | 49 | 49 | 49 | 44 | 43 | |
| Shares Outstanding (Diluted) | 49 | 49 | 49 | 49 | 44 | 43 | |
| Shares Change (YoY) | -0.00% | 0.00% | 0.92% | 9.42% | 2.91% | 4.95% | |
| EPS (Basic) | -0.21 | -0.17 | -0.29 | -0.21 | -0.31 | -0.30 | |
| EPS (Diluted) | -0.21 | -0.17 | -0.29 | -0.21 | -0.31 | -0.30 | |
| Free Cash Flow | -9.21 | -7.45 | -12.92 | -9.41 | -10.86 | -9.14 | |
| Free Cash Flow Per Share | -0.19 | -0.15 | -0.26 | -0.19 | -0.24 | -0.21 | |
| Gross Margin | - | 100.00% | - | 100.00% | - | - | |
| Operating Margin | - | -990.03% | - | -253.02% | - | - | |
| Profit Margin | - | -857.15% | - | -251.00% | - | - | |
| Free Cash Flow Margin | - | -745.23% | - | -233.07% | - | - | |
| EBITDA | -11.96 | -9.88 | -14.61 | -10.19 | -14.16 | -14.01 | |
| EBITDA Margin | - | - | - | -252.38% | - | - | |
| D&A For EBITDA | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | |
| EBIT | -11.98 | -9.9 | -14.63 | -10.22 | -14.18 | -14.03 | |
| EBIT Margin | - | - | - | -253.02% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.